AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 127 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,385,558 | +50.5% | 58,398 | -6.0% | 0.00% | +50.0% |
| Q1 2024 | $1,584,894 | +182.6% | 62,104 | +0.2% | 0.00% | +100.0% |
| Q4 2023 | $560,774 | +45.4% | 61,964 | +2.5% | 0.00% | 0.0% |
| Q3 2023 | $385,779 | -40.6% | 60,467 | +3.3% | 0.00% | 0.0% |
| Q2 2023 | $649,064 | -26.1% | 58,527 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $878,358 | -48.4% | 57,222 | -25.5% | 0.00% | -66.7% |
| Q4 2022 | $1,703,793 | +38.3% | 76,782 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $1,232,000 | -32.6% | 75,462 | -40.0% | 0.00% | -25.0% |
| Q2 2022 | $1,828,000 | +43.5% | 125,832 | +82.5% | 0.00% | +100.0% |
| Q1 2022 | $1,274,000 | -61.2% | 68,967 | -50.0% | 0.00% | -60.0% |
| Q4 2021 | $3,280,000 | -48.0% | 138,008 | -46.1% | 0.01% | -58.3% |
| Q3 2021 | $6,312,000 | +17934.3% | 256,268 | +18204.9% | 0.01% | – |
| Q2 2021 | $35,000 | +12.9% | 1,400 | 0.0% | 0.00% | – |
| Q1 2021 | $31,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |